title: Alterations in conjunctival bacteria and antimicrobial susceptibility during topical administration of ofloxacin after cataract surgery in dogs.
abstract: OBJECTIVE To evaluate changes in conjunctival bacteria and antimicrobial susceptibility of bacteria after cataract surgery in dogs. ANIMALS 16 client-owned dogs. PROCEDURES Samples for aerobic and anaerobic culture were obtained from the conjunctival fornices of both eyes of dogs 24 hours before (week 0) and 1, 3, and 6 weeks after cataract surgery. Topical administration of ofloxacin (every 6 hours) was initiated 12 hours before surgery and continued for 3 weeks. In vitro antimicrobial susceptibility was determined by Kirby-Bauer disk diffusion and a commercially available test for ofloxacin. RESULTS Frequency of positive culture results was significantly higher at week 6 than at weeks 0 and 1. Bacterial load was more likely to be moderate or high at weeks 3 and 6 than at weeks 0 and 1. The most frequently cultured organism was Staphylococcus pseudintermedius (21/78 [26.9%]), followed by coagulase-negative Staphylococcus spp (19/78 [24.4%]). Staphylococcus pseudintermedius was the organism most frequently cultured at weeks 0 (5/12), 1 (4/12), and 6 (8/19), whereas frequency of this organism was lowest at week 3 (1/20). In contrast, coagulase-negative Staphylococcus spp were the most frequently cultured organisms at week 3 (10/20). There was a significant increase in the proportion of organisms resistant to ofloxacin at week 3, compared with the proportion at week 0. CONCLUSIONS AND CLINICAL RELEVANCE The number of bacterial organisms increased and the population of conjunctival bacteria was altered and had a higher proportion resistant to ofloxacin during the 6 weeks after cataract surgery for dogs treated by use of this protocol.
authors.forename: Lynne S
authors.initials: LS
authors.lastname: Sandmeyer
authors.forename: Bianca S
authors.initials: BS
authors.lastname: Bauer
authors.forename: Seyed Mohammad
authors.initials: SM
authors.lastname: Mohaghegh Poor
authors.forename: Cindy Xin
authors.initials: CX
authors.lastname: Feng
authors.forename: Manuel
authors.initials: M
authors.lastname: Chirino-Trejo
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002386:Cataract / Q000662:veterinary*; D002387:Cataract Extraction / Q000662:veterinary*; D003228:Conjunctiva / Q000382:microbiology; D004283:Dog Diseases / Q000601:surgery*; D004285:Dogs; D024881:Drug Resistance, Bacterial; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D009883:Ophthalmic Solutions / Q000494:pharmacology / Q000627:therapeutic use*; D013210:Staphylococcus / Q000187:drug effects
chemical_list: D000890:Anti-Infective Agents; D009883:Ophthalmic Solutions; D015242:Ofloxacin